Search

everythinglearnresearchcommunity

for

Search:↓

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Enzymes called PADIs play a key role in hair growth and loss.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Vitamin D might help treat some types of hair loss, but more research is needed.

Gut health affects skin diseases, and probiotics might help.

WNT signaling is crucial for skin development and healing.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

CBD may improve skin and hair health, but its effective use and safety need more research.